Despite localization of mGIPR-Ab/P3 predominantly in CVOs, and not in deeper parenchyma of the brain, c-Fos activation was observed in multiple neural substrates involved in food intake control 21,22,23,24,25,26,27,28,29,30 (Fig
Enhancing insulin secretion in response to food GLP-1s stimulate the pancreas to release insulin only when blood sugar levels are elevated, reducing the risk of hypoglycemia (low blood sugar)
It is not a replacement for GLP-1 medications in people who need them medically
These foods are rich in plant compounds that help nourish beneficial gut bacteria, which in turn play a role in regulating appetite hormones
New-User design and landmark analysis A new-user design restricted the population to patients without prior SGLT-2 inhibitor or GLP-1 RA exposure before the index date [30]
Healthcare providers can provide a personalized treatment plan by adjusting the doses of both drugs for optimal outcomes with minimal side effects